This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Milford, MA-based, Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company’s products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. Waters Division (88.8% of total revenues in 2019) - High Performance and Ultra Performance Liquid Chromatography (HPLC and UPLC). TA Division (11.2% of total revenues in 2019)- Thermal Analysis, Rheometry and Calorimetry.
Waters (WAT) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Waters' (WAT) fourth-quarter 2021 results are likely to reflect solid momentum across pharmaceutical and industrial end markets.
Analysts Estimate Waters (WAT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Waters (WAT) Boosts Mass Spectrometry Via MS Quan Application
by Zacks Equity Research
Waters (WAT) releases the MS Quan application on the waters_connect informatics software platform to help scientists efficiently screen large number of samples and contaminants.
Waters (WAT) Down 5.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) Q3 Earnings & Revenues Beat Estimates, Rise Y/Y
by Shilpa Mete
Waters' (WAT) third-quarter results reflect gains from strong momentum across pharmaceutical and industrial end-markets.
Waters (WAT) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Waters (WAT) delivered earnings and revenue surprises of 13.68% and 1.07%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Waters (WAT) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Waters' (WAT) third-quarter 2021 results are likely to reflect strength across liquid chromatography instruments and mass spectrometers.
Waters (WAT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights: Mettler-Toledo International, PerkinElmer and Waters Corp
by Zacks Equity Research
Zacks Industry Outlook Highlights: Mettler-Toledo International, PerkinElmer and Waters Corp
3 Stocks to Watch on Rising Demand for Scientific Instruments
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), PerkinElmer (PKI) and Waters Corporation (WAT) are gaining from strong life science, pharmaceutical and academic end-market demand as well as rising healthcare spending.
Waters (WAT) BioAccord System to Expand Portfolio Offerings
by Zacks Equity Research
Waters (WAT) introduces Waters BioAccord System with ACQUITY Premier for seamless monitoring of attributes of biotherapeutics.
Waters (WAT) Up 5.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Waters (WAT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Can Waters (WAT) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Waters (WAT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Himax (HIMX) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Himax's (HIMX) Q2 earnings are likely to have gained from strength witnessed in its small- and medium-sized display driver IC business.
Zillow Group (ZG) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Zillow Group's (ZG) Q2 performance is likely to reflect strength in IMT and Mortgage segments.
Waters (WAT) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Waters' (WAT) second-quarter results reflect gains from strong momentum across pharmaceutical, industrial, and governmental and academic markets.
Diodes (DIOD) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Diodes' (DIOD) second-quarter results are likely to benefit from robust adoption of its products in the automotive, industrial, communications and computing end-markets.
What's in Store for Kulicke and Soffa (KLIC) in Q3 Earnings?
by Zacks Equity Research
Kulicke and Soffa's (KLIC) third-quarter fiscal 2021 results are expected to benefit from strong demand for its solutions in the semiconductor, automotive and LED end-markets.
Fastly (FSLY) Set to Report Q2 Earnings: What to Expect?
by Zacks Equity Research
Fastly's (FSLY) second-quarter 2021 results are expected to benefit from higher bandwidth usage and an expanding clientele.
Waters (WAT) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Waters' (WAT) second-quarter 2021 results are likely to reflect strength across liquid chromatography instruments and mass spectrometers.
Waters (WAT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mettler-Toledo (MTD) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Mettler-Toledo's (MTD) second-quarter results are likely to reflect benefits of strong momentum across laboratory, industrial and retail businesses.
What's in Store for United Microelectronics (UMC) Q2 Earnings?
by Zacks Equity Research
United Microelectronics' (UMC) second-quarter results are expected to reflect the impacts of strength across 28 nm and 22 nm shipments.
What's in the Cards for TE Connectivity's (TEL) Q3 Earnings?
by Zacks Equity Research
TE Connectivity's (TEL) fiscal third-quarter results are expected to reflect solid momentum across the Transportation and Communication segments amid coronavirus-led headwinds.